Andre Zimerman, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tachycardia, Supraventricular | 1 | 2021 | 263 | 0.660 |
Why?
|
Science | 1 | 2020 | 241 | 0.620 |
Why?
|
Exercise Test | 3 | 2023 | 2074 | 0.560 |
Why?
|
Speech | 1 | 2021 | 540 | 0.550 |
Why?
|
Bullying | 1 | 2018 | 210 | 0.520 |
Why?
|
Automobile Driving | 1 | 2019 | 431 | 0.490 |
Why?
|
Heart Failure | 7 | 2023 | 10900 | 0.470 |
Why?
|
Electrocardiography | 5 | 2021 | 6442 | 0.450 |
Why?
|
Attitude | 1 | 2018 | 776 | 0.450 |
Why?
|
Myocardial Revascularization | 1 | 2016 | 841 | 0.400 |
Why?
|
Acute Coronary Syndrome | 3 | 2022 | 2337 | 0.350 |
Why?
|
Brazil | 5 | 2020 | 1270 | 0.350 |
Why?
|
Suicidal Ideation | 1 | 2018 | 1248 | 0.340 |
Why?
|
Tachycardia, Ventricular | 1 | 2017 | 1273 | 0.330 |
Why?
|
Poverty | 1 | 2020 | 2660 | 0.330 |
Why?
|
Cardiomyopathies | 2 | 2017 | 1912 | 0.320 |
Why?
|
Heart Function Tests | 2 | 2016 | 330 | 0.260 |
Why?
|
Myocardial Infarction | 4 | 2022 | 11727 | 0.240 |
Why?
|
Catheter Ablation | 1 | 2017 | 2758 | 0.240 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 3068 | 0.220 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5034 | 0.200 |
Why?
|
Ventricular Function, Left | 4 | 2021 | 3670 | 0.200 |
Why?
|
Physicians | 1 | 2019 | 4567 | 0.200 |
Why?
|
Metoprolol | 1 | 2021 | 93 | 0.190 |
Why?
|
Anticoagulants | 1 | 2016 | 4599 | 0.190 |
Why?
|
Ventricular Pressure | 1 | 2021 | 199 | 0.180 |
Why?
|
Furosemide | 1 | 2019 | 167 | 0.170 |
Why?
|
Peer Review, Research | 1 | 2022 | 329 | 0.160 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2019 | 135 | 0.160 |
Why?
|
Oxygen Consumption | 2 | 2023 | 1869 | 0.160 |
Why?
|
Florida | 1 | 2019 | 435 | 0.160 |
Why?
|
Stroke Volume | 5 | 2023 | 5007 | 0.150 |
Why?
|
Risk Assessment | 2 | 2016 | 23338 | 0.150 |
Why?
|
Atrial Premature Complexes | 1 | 2016 | 17 | 0.150 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2021 | 789 | 0.140 |
Why?
|
Endocardium | 1 | 2017 | 263 | 0.140 |
Why?
|
Prosthesis Implantation | 1 | 2020 | 642 | 0.130 |
Why?
|
Ventricular Premature Complexes | 1 | 2016 | 111 | 0.130 |
Why?
|
Lactic Acid | 1 | 2020 | 1133 | 0.130 |
Why?
|
Withholding Treatment | 1 | 2019 | 599 | 0.130 |
Why?
|
Shock, Cardiogenic | 1 | 2020 | 688 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2021 | 851 | 0.130 |
Why?
|
Gold | 1 | 2017 | 484 | 0.120 |
Why?
|
Prognosis | 5 | 2023 | 29063 | 0.110 |
Why?
|
Patient Admission | 1 | 2021 | 1380 | 0.110 |
Why?
|
Outpatients | 1 | 2020 | 1486 | 0.110 |
Why?
|
Vaccination | 2 | 2022 | 3278 | 0.110 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1573 | 0.110 |
Why?
|
Pyridones | 1 | 2017 | 712 | 0.110 |
Why?
|
Humans | 24 | 2023 | 744343 | 0.100 |
Why?
|
Caffeine | 1 | 2016 | 699 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 2 | 2021 | 1541 | 0.100 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 1440 | 0.100 |
Why?
|
Cicatrix | 1 | 2017 | 764 | 0.100 |
Why?
|
Influenza, Human | 1 | 2022 | 1479 | 0.100 |
Why?
|
Middle Aged | 11 | 2023 | 213383 | 0.100 |
Why?
|
Mothers | 1 | 2021 | 2165 | 0.100 |
Why?
|
Canada | 1 | 2016 | 2065 | 0.090 |
Why?
|
Coronary Artery Bypass | 1 | 2020 | 2289 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1587 | 0.090 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1354 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2018 | 1151 | 0.090 |
Why?
|
Genetic Markers | 1 | 2016 | 2634 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2020 | 0.090 |
Why?
|
Europe | 1 | 2016 | 3339 | 0.080 |
Why?
|
Double-Blind Method | 3 | 2019 | 12026 | 0.080 |
Why?
|
Peptide Fragments | 1 | 2020 | 5097 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 2016 | 1148 | 0.080 |
Why?
|
Ultrasonography | 1 | 2021 | 5985 | 0.080 |
Why?
|
Chronic Disease | 1 | 2023 | 9146 | 0.080 |
Why?
|
Male | 12 | 2023 | 350118 | 0.080 |
Why?
|
United States | 4 | 2021 | 69872 | 0.080 |
Why?
|
Data Collection | 1 | 2017 | 3341 | 0.080 |
Why?
|
Stroke | 2 | 2022 | 9981 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 1 | 2016 | 2268 | 0.070 |
Why?
|
Pyrazoles | 1 | 2017 | 1972 | 0.070 |
Why?
|
Hemorrhage | 1 | 2017 | 3461 | 0.060 |
Why?
|
Survival Rate | 2 | 2016 | 12788 | 0.060 |
Why?
|
Female | 11 | 2023 | 380194 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2023 | 7659 | 0.060 |
Why?
|
Patient Discharge | 1 | 2016 | 3313 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9856 | 0.050 |
Why?
|
Vaccines, Inactivated | 1 | 2022 | 184 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39050 | 0.050 |
Why?
|
Oxygenators, Membrane | 1 | 2020 | 56 | 0.050 |
Why?
|
Incidence | 2 | 2016 | 20947 | 0.050 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 176 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.050 |
Why?
|
New York | 1 | 2023 | 886 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9959 | 0.050 |
Why?
|
Risk Factors | 4 | 2021 | 72290 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 549 | 0.040 |
Why?
|
Diastole | 1 | 2021 | 791 | 0.040 |
Why?
|
Body Fluids | 1 | 2019 | 319 | 0.040 |
Why?
|
Protein Precursors | 1 | 2020 | 1154 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2021 | 1119 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 77449 | 0.030 |
Why?
|
Safety | 1 | 2019 | 1186 | 0.030 |
Why?
|
Systole | 1 | 2016 | 958 | 0.030 |
Why?
|
Adult | 4 | 2021 | 214055 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2016 | 585 | 0.030 |
Why?
|
Self Concept | 1 | 2019 | 1025 | 0.030 |
Why?
|
Aged | 4 | 2021 | 163280 | 0.030 |
Why?
|
Dyspnea | 1 | 2019 | 1303 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2029 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5078 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14722 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2016 | 719 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 53288 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2017 | 1530 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 1194 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2022 | 63114 | 0.020 |
Why?
|
Adolescent | 1 | 2018 | 85781 | 0.020 |
Why?
|
Causality | 1 | 2016 | 1275 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10252 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40075 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2016 | 19905 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12354 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2016 | 2148 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2016 | 2073 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15076 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3610 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3444 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
Blood Pressure | 1 | 2016 | 8554 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 13989 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 13881 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
Child | 1 | 2021 | 77709 | 0.010 |
Why?
|